Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Alpha-9 Oncology USA Inc.
MonTa Biosciences ApS
OncoNano Medicine, Inc.
Modulation Therapeutics, Inc.
Novelty Nobility, Inc.